PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ARSENIC AND COMPOUNDS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 415 records · Page 23Linked to original sources

Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics.

To elucidate if the metabolic methylation participates in the induction of inorganic arsenic-responsible genetic damage, arsenite (ARS) and its methylated metabolites, methanearsonic acid (MMAA) and dimethylarsinic acid (DMAA), were comparatively assayed for the induction of DNA damage by determining DNA repair synthesis using polymerization inhibitors such as aphidicolin (aph) and hydroxyurea (HU). When human alveolar epithelial type II (L-132) cells in culture were exposed to either one of these three arsenic compounds, DNA single-strand breaks resulting from the inhibition of repair polymerization were remarkably produced by exposure to DMAA at 5 to 100 microM, while not by that to ARS and MMAA even at 100 microM. Furthermore, a bromodeoxyuridine (BrdrU)-photolysis assay indicated that the induction of DNA repair synthesis was observed only in the case of exposure to DMAA. When L-132 cells were exposed to 100 microM MMAA in the presence of 10 mM S-adenosyl-L-methionine (SAM), which is a well-known methyl-group donor in metabolic methylation of arsenics, DNA repair synthesis was induced along with an increase in the amount of dimethylarsenic in the cells. These results indicate that metabolic methylation of inorganic arsenics to dimethylarsenics is predominantly involved in the induction of DNA damage.

Arsenic Poisoning↗

Identification of methylated metabolites of inorganic arsenic by thin-layer chromatography.

TLC on cellulose plates was used to identify methylated products of inorganic arsenic metabolism (monomethylarsonate and dimethylarsinate) in biological samples. Two solvent systems were tested: methanol-ammonium hydroxide (8:2) and isopropanol-acetic acid-water (10:1:2.5). The latter solvent system produced the most satisfactory separation of radiolabelled methylated arsenic compounds in aqueous solution, in rat liver cytosol incubated with carrier-free or 1 microM [73As]arsenite and in urine of mice given carrier-free [73As]arsenate or 5 mg of [73As]arsenate/kg per os. Oxidation of samples by hydrogen peroxide improved the separation and quantitation of monomethylarsonate in both biological matrices.

Animals↗

Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway.

In the present study, we investigated the effect of tetraarsenic oxide (As4O6, 2,4,6,8,9,10-Hexaoxa-1,3,5,7-tetraarsatricyclo[3.3.1.13,7]decane) upon induction of apoptosis in arsenic trioxide (diarsenic oxide, As2O3) resistant U937 leukemic cells. As4O6 induced apoptosis in U937 leukemic cells at much lower concentrations than As2O3 via an early increase of cellular reactive oxygen species (ROS), and a decrease in cellular mitochondrial membrane potential, followed by cytochrome c release and caspase-3 activation. As4O6 generated ROS and induced caspase-3 activation more potently than As2O3 in U937 cells. Incubation of the cells with N-acetyl-L-cysteine and catalase resulted in significant suppression of As4O6-induced apoptotic cell death. These results show that the generation of ROS leads to the consequences associated with apoptosis induced by As4O6. In conclusion, As4O6 might be a new arsenic compound which may induce apoptosis in U937 leukemic cells by activating unique apoptotic signaling mediated by ROS more potently than As2O3, and deserves further evaluation.

Apoptosis↗

Treatment concepts of acute promyelocytic leukemia.

In the past, acute promyelocytic leukemia (APL) was associated with a high risk of early mortality resulting from severe coagulopathy, frequently inducing fatal cerebral hemorrhage. With the introduction of the differentiating agent all-trans retinioc acid (ATRA) APL has changed to the best curable subtype of acute myeloid leukemia (AML). With ATRA and chemotherapy approximately 70-80% of patients with newly diagnosed APL achieve long-term remission and are probably cured. PML/RARalpha, the molecular fusion transcript of the specific translocation t(15;17) represents not only the target for ATRA but also permits a precise diagnosis and provides a marker for the identification of minimal residual or recurrent disease (MRD). During the last decade, substantial progress has been made with regard to the recognition of prognostic factors and the optimization of the combination of ATRA and chemotherapy. Remaining questions are the role of arsenic and of ara-C in first line therapy of APL as well as the indication of maintenance therapy in the individual patient. Several treatment options exist for patients with APL who have relapsed after ATRA and chemotherapy. Approximately 50% of the patients in first relapse can achieve long-lasting second remission and might be cured with salvage regimens. Currently, arsenic compounds and transplantation procedures seem to be the most promising options in relapsed disease. The role of CD33 antibodies has to be determined in future studies. Refining the molecular monitoring of MRD by quantitative RT-PCR, better elucidation of the biologic mechanisms, and the identification of prognostic factors might be helpful to make further progress in the treatment of APL.

Antineoplastic Agents↗

[Development of analysis of drugs and toxic substances that can play an immediate role in emergency medical service: what is to be analyzed?].

Our laboratory was capable of analyzing less than 20 drugs and toxic substances at the time of the establishment of the Center in 1994. Since the poisoning crimes in 1998, such as the curry poisoning with arsenic in Wakayama, the sodium azide poisoning in Niigata, and the potassium cyanide poisoning in Nagano, we have introduced methods for rapid qualitative analysis of arsenic compounds, cyanides and azides, and developed methods for qualitative analysis of three types of surfactants (cationic, anionic, and nonionic) on the basis of the statistics for intoxication patients transferred to the Center. In 1999, the Analysis Method Investigation Committee of the Japanese Society for Clinical Toxicology requested individual medical institutions to analyze 15 selected intoxicating substances, focusing on the following three aspects. 1. Intoxication with a high degree of fatality. 2. Intoxication where analysis plays an immediate role in treatment. 3. Intoxication with a high frequency of requests by clinical physicians for analysis. The selected substances included methanol, barbital drugs, benzodiazepines, tricyclic or tetracyclic antidepressants, methamphetamine, acetaminophen, salicylic acid, bromovalerylurea, organophosphorus pesticides, carbamate pesticides, paraquat, glufosinate, cyanides, arsenic, and theophylline. Responding to the Committee's request, out laboratory has been making efforts so that analysis of drugs and intoxicating substances can play an immediate role in emergency medical service, giving the highest priority to the aforementioned 15 substances. As a result, anyone of us can now rapidly analyze about 35 substances, including those listed by the Society, day and night.

Chemistry Techniques, Analytical↗

Urinary arsenic species in Devon and Cornwall residents, UK. A pilot study.

First void urine samples were collected from 24 residents in an area of past intense mining and smelting activity of arsenical ores. Seven samples were also taken from a control village. The arsenic species in the urine were separated and quantified with an HPLC-ICP-MS system equipped with a hydraulic high-pressure nebulizer. The detection limit for arsenic in urine using this system is 0.05 microgram dm-3. Creatinine was also determined for all samples to remove the influence of urine density and all results were expressed in microgram As g-1 creatinine. The results showed elevated levels of both organic and inorganic arsenic compounds in the 'exposed' population's urine when compared with those of the control group. The total As concentrations (less arsenobetaine) in the 'exposed' population were in the range 2.7-58.9 micrograms g-1 creatinine (mean 13.4, median 9.2 micrograms g-1) compared with the control group data range 2.5-5.3 micrograms g-1 (mean 4.2, median 4.7 micrograms g-1).

Adolescent↗

Involvement of vicinal dithiols in differential regulation of fMLP and phorbol ester-activated phospholipase D in stimulated human neutrophils.

In the human neutrophil, the fMLP-activated phospholipase D (PLD) was entirely calcium and tyrosine kinase dependent, but protein kinase C independent. An opposite regulation was observed with phorbol ester PMA, since the phospholipase D activity was mostly calcium insensitive, tyrosine kinase independent, but protein kinase C dependent. The arsenical compound, phenylarsine oxide (PAO), which reacts with vicinal sulhydryl groups, activated twofold at one minute the PMA stimulated-PLD activity, whereas it inhibited half of the fMLP-activated PLD after a time lag of 30 sec. Our data indicate that PAO acted on a mechanism regulating the balance between fMLP-activated and PMA-activated phospholipase D activity. Noteworthy, PAO similarly inhibited fMLP and PMA-induced O2(-)-production.

Arsenicals↗

Genotoxicity testing of arsenobetaine, the predominant form of arsenic in marine fishery products.

Marine fishery products may contain high levels of arsenic, mainly in the form of organic arsenic compounds. Arsenobetaine has been identified as the predominant form occurring in marine fishery products. The potential initiating and promoting capacities of this compound were therefore investigated in vitro. In the Salmonella typhimurium assay, no mutagenicity was observed in strains TA97, TA98 and TA100 without activation or after addition of a liver-enzyme fraction or gut-flora extract. The compound was also negative in the forward mutation assay of the HGPRT gene and in the test for sister chromatid exchanges in V79 Chinese hamster cells. No inhibition of metabolic co-operation between V79 Chinese hamster cells was observed at arsenobetaine concentrations up to 10 mg/ml. In addition, arsenobetaine had no synergistic or antagonistic effects on the action of the positive controls benzo[a]pyrene and tetradecanoylphorbol-13-acetate.

4-Nitroquinoline-1-oxide↗

Hypersensitivity to mitomycin C-induced sister chromatid exchange as a biomarker of past exposure to arsenic.

The objective of this study was to determine if cytogenetic markers can be used as indicators of prior exposure to arsenic compounds. Baseline sister chromatid exchange (SCE) and mitomycin C-induced (MMC) SCE were measured in four study populations recruited from a blackfoot (BF) disease endemic area, including 22 patients with cancer (CA) only, 8 patients with both BF disease and CA (BF+CA), 10 patients with BF disease only, and 26 healthy residents (HRs). Another group of 23 healthy, nonarsenic-exposed workers were recruited as external healthy controls (HCs). Characteristics of study population were collected by questionnaire, and 10 ml of venous blood were drawn for lymphocyte culture. The results showed that the frequencies of baseline SCE did not differ among the five study groups. The frequencies of delta SCE (MMC-induced SCE minus baseline SCE) in CA only, BF disease only, and HRs, three arsenic-exposed groups, were significantly higher than in HCs. The frequency of delta SCE in the BF+CA group was nonsignificantly higher than in HCs, probably due to small sample size. The frequencies of both baseline SCE and delta SCE did not differ among CA only, BF disease only, BF+CA, and HR groups. The observation that baseline SCE did not increase in the arsenic-exposed populations indicates either that exposures were insufficiently high to change this marker or that lesions did not persist. The increased SCE response to MMC in arsenic-exposed populations suggests that previous arsenic exposure may result in hypersensitivity of human lymphocytes to carcinogens and/or mutagens. Both baseline SCE and delta SCE were not different among patients with arsenic-induced diseases and healthy normal residents, indicating that hypersensitivity may have been due to previous arsenic exposure but was not associated with disease status.

Aged↗

Choroid plexus protects cerebrospinal fluid against toxic metals.

Although heavy metal ions are known to be toxic to the central nervous system (CNS), the mechanisms by which the CNS may protect itself from initial challenges of such toxic ions is unknown. The choroid plexus is the principal site of formation of the cerebrospinal fluid (CSF) which bathes the brain. We have determined in rats and rabbits that after intraperitoneal administration of lead, cadmium, mercury, and arsenic compounds, these toxic metal ions accumulated in the lateral choroid plexus at concentrations of Pb, Hg, and As that were 70-, 95-, and 40-fold higher, respectively, than those found in the CSF. Cd was not detected in the CSF. In addition, concentrations of these heavy metal ions were found to be many fold greater in the choroid plexus than in the brain or blood. The accumulation of Pb in the choroid plexus was dose-dependent and time-related. When the choroid plexus was preincubated, in vitro, with ouabain (1.5 mM), the uptake of Cd from the CSF side of the choroid plexus was inhibited 57%. Cadmium metallothionein was not found in the choroid plexus. Whereas the concentration of reduced glutathione in the choroid plexus was less than that in the brain cortex, the concentration of cystine was fourfold greater. The lateral choroid plexus sequesters Pb, Cd, As, and Hg. It appears to be one of the important mechanisms that protects the CSF and the brain from the fluxes of toxic heavy metals in the blood.

Animals↗

Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi.

The trypanocidal activity of an arsenical compound (RM 110; mel Cy; Cymelarsan) was evaluated against Trypanosoma brucei brucei and T. brucei evansi in cultures, in goats and pigs. The trypanosome stocks used differed in their levels of susceptibility to cymerlarsan in an in vitro test, their IC50 values (drug concentration which inhibits growth by 50%) ranging from 4.8-5.1 nM for susceptible, and 26.9 nM for a resistant stock. Goats infected with a susceptible T.b. evansi stock were cured after a single injection of 0.3 mg/kg cymelarsan. In three out of four goats chronically infected with the same stock a single injection of 0.625 mg/kg cymelarsan effected a cure, whereas the goat in which the infection relapsed was finally cured after injection of 0.625 mg/kg on each of three consecutive days. A single dose of 2.5 mg/kg did not cure goats infected with an arsenical-resistant T.b. brucei stock. One of two pigs chronically infected with arsenical-susceptible stocks of T.b. brucei was cured after a single injection of 0.625 mg/kg cymelarsan, whereas the other one relapsed and died. In conclusion, the results may indicate that the dose of 0.25 mg/kg recommended by the manufacturer is too low and that a single may not cure animals with CNS involvement with certainty. The recommended dose might therefore have been applied strictly for the treatment of camels only.

Animals↗

Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells.

We investigated the cytogenetic effects of dimethylarsinic acid (DMA), which is the major metabolite of inorganic arsenic compounds, on mouse bone marrow cells after a single intraperitoneal injection to mice. DMA increased mitotic indices significantly at 16, 24 and 48 h after injection, and prolonged the average generation time 1.5 h at the 24 h. These results suggest that DMA may cause mitotic arrest in vivo as well as in vitro. However the activity of mitotic arrest induced by DMA was much weaker than that induced by colchicine. Metaphase cells obtained after administration of DMA without colchicine pretreatment were morphologically normal except for chromosome number, which varied by stage from the prophase to the telophase in M phase as seen after administration of saline. DMA significantly induced aneuploids. The frequencies of euploids with DMA and saline treatment were 55.1 and 94.0%, respectively, and in DMA treatment hyperploids with 1 or 2 extra chromosomes were over 80% of all aneuploids. These results suggest that aneuploidy induced by DMA might be associated with carcinogenicity of arsenic.

Aneuploidy↗

Uptake and elimination of arsenobetaine by the mussel Mytilus edulis is related to salinity.

The high concentrations of the naturally occurring arsenic compound arsenobetaine in marine animals, in comparison with freshwater animals, has led to the suggestion that salinity is a factor in its accumulation. In separate experiments, we investigated the uptake and elimination of arsenobetaine by the mussel Mytilus edulis when maintained under three salinity regimes (32, 24, and 16 practical salinity units). Both uptake and elimination of arsenobetaine depended on the salinity of the water in a manner leading to higher concentrations at the higher salinity. The data are consistent with a proposed role of arsenobetaine as an adventitiously acquired osmolyte, and readily explain field data for freshwater and marine animals.

Animals↗

Damage to Reissner's membrane in the guinea-pig cochlea following acute atoxyl intoxication.

The ototoxic effects of the arsenic compound atoxyl has been earlier demonstrated by Anniko & Wersäll (1975) in the stria vascularis of the guinea pig cochlea. The aim of the present investigation was to study the morphological degeneration at the ultrastructural level after damaging the Reissner's membrane experimentally. In acute atoxyl intoxication the first signs of degeneration appear after approximately 12 hours. After 24 hours, the membrane may be markedly degenerated. Both the epithelial and mesothelial cells become vacuolized, the mitochondria lose their internal structure and become swollen, and lipid granules are found in the cytoplasm. Mesothelial cells are damaged to a lesser extent than the epithelial cells in the same specimen.

Animals↗

A practical phasing procedure using the MAD method without the aid of XAFS measurements: successful solution in the structure determination of the outer-membrane lipoprotein carrier LolA.

A practical procedure for MAD phasing was successfully performed in the structure determination of the LolA protein, even though the XAFS data could not be measured owing to the overlap of the fluorescence spectra of the atoms that contribute significant signals for anomalous dispersion. The LolA protein, a periplasmic chaperone functioning as an outer-membrane lipoprotein carrier of the Lol system which mediates translocation of the water-insoluble outer-membrane lipoprotein across the periplasm in Gram-negative bacteria, was crystallized in two forms: orthorhombic (I222) and trigonal (P3(1)21 or P3(2)21). A multi-wavelength data set was collected from a platinum derivative of the orthorhombic crystals grown from a buffer solution containing zinc acetate and cacodylate (an arsenic compound), but XAFS measurements could not be performed because the energies of the fluorescence spectra of Zn atoms, As atoms and Pt atoms are in very close proximity. However, effective MAD data were collected with six wavelength data sets near the platinum absorption edge and the f' and f" values could subsequently be estimated from the data statistics and the peak height of the dispersive and anomalous difference Patterson maps. The subsequent MAD phasing gave a high-quality initial electron-density map which was sufficient to construct a complete molecular model of the LolA protein.

Arsenic↗

Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.

Arsenic metabolism has typically been studied by administering arsenate or arsenite into animals and humans and then studying the metabolites excreted in the urine. Although such studies have yielded information about the beginning and the end of the metabolic pathways for the metabolism of inorganic arsenic compounds, any statements as to the molecular mechanisms of these reactions have had to be highly speculative. Now that the rabbit and the rhesus monkey liver enzymes that transfer methyl groups from S-adenosylmethionine to arsenite and monomethlyarsonic acid have been purified and the reactions characterized, meaningful investigations of species diversity and polymorphism of these enzymes have become possible. New World animals studied thus far appear to be deficient in or totally lacking these enzymes. Old World animals, with the exception of the chimpanzee, have ample amounts of arsenite and monomethylarsonic acid methyltransferases. A hypothesis that the lack of arsenite methyltransferases may have had an evolutionary advantage for certain species is proposed.

Animals↗

Cellular metabolism of arsenocholine.

The biotransformation of arsenocholine and arsenobetaine, which are organic arsenic compounds present in certain aquatic organisms, has been studied in vitro using synthetic reference substances. Incubation of arsenocholine with different liver cell fractions showed arsenocholine to be biotransformed only in presence of the mitochondrial fraction. The biotransformation products were arsenobetaine aldehyde, arsenobetaine, trimethylarsine oxide and trimethylarsine. Arsenobetaine was the major metabolite and it was formed via arsenobetaine aldehyde. Trimethylarsine oxide was formed via a side reaction from arsenobetaine aldehyde. Further reduction of trimethylarsine oxide, produced trimethylarsine. In vitro studies of arsenobetaine, did not show any formation of trimethylarsine oxide or trimethylarsine. Furthermore, cytotoxicity of arsenobetaine or arsenocholine in isolated hepatocytes was not observed.

Alcohol Oxidoreductases↗

[Exposure to agricultural chemicals and oncogenic risk].

The authors review the available evidence on cancer risk associated with exposure to agricultural chemicals. Agricultural workers generally show a lower cancer mortality compared with other occupational categories. This observation is currently believed to be due to lower cigarette consumption. However, for some types of tumours (lymphoma, leukaemia, myeloma, soft tissue sarcoma, skin, prostate, brain and stomach tumours), mortality is higher among agricultural workers. The only chemical substances used in agriculture for which the IARC Monographs have established the existence of sufficient evidence of carcinogenicity for man are arsenical compounds and mineral oils; for other substances there is clear evidence of carcinogenicity in experimental animals, mostly in the absence of human data. In the case of exposure to phenoxyacetic herbicides, the available epidemiological evidence is contradictory, with excesses of non-Hodgkin lymphoma and soft tissue sarcoma reported in some studies but not in others. Cohort studies have been performed among insecticide production workers and spray operators (with excesses of lung tumour), and among grain processing workers (with excesses of non-Hodgkin lymphoma in particular). A number of case-control studies are also available, especially concerning tumours of the lymphatic and haemopoietic systems and ovarian tumours.

Agricultural Workers' Diseases↗